MTOR and tuberous sclerosis: Importantly, mTOR inhibitors have demonstrated efficacy in treating such tumors and reducing their size, as well as in alleviating neurological symptoms in TSC patients [37], thereby improving clinical outcomes and enhancing the quality of life for those undergoing such treatments.